Building not operational until 2019, says CEO
US insurers are covering the treatment, despite high price.
This week’s news
Siliq will be cheaper than rivals from Novartis and Eli Lilly.
Healios endorsed for improving access to CBT for young people with anxiety.
Genfit was among a group of NASH companies publishing updates at the International Liver Congress.
FDA approves Samsung Bioepis biosimilar.
Firm looking to create something similar to its recent deal with UnitedHealthcare.
Trial backs patient-friendly regime in tough to treat strain.
Depakine and generics linked with defects including spina bifida.
Order comes after man commits suicide taking generic version of GSK’s Paxil.
Funding will go towards expanding worldwide brand.
FDA hands out new indications for Tecentriq and Lucentis.